Teva Pharmaceutical-Sp Adr
Investors holding0
Combined shares0
Combined reported value$0
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Cathie Wood | 0.00 | Closed | 0 | – | Q3 2026 |
| Ray Dalio | 0.00 | Closed | 0 | – | Q3 2026 |
| Stanley Druckenmiller | 0.00 | Closed | 0 | – | Q3 2026 |
| Larry Robbins | 0.00 | Closed | 0 | – | Q3 2026 |
| David Einhorn | 0.00 | Closed | 0 | – | Q3 2026 |
| Paul Tudor Jones | 0.00 | Closed | 0 | – | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Larry Robbins | Closed | 0 | 3.44 |
| Q3 2026 | David Einhorn | Closed | 0 | 2.50 |
| Q3 2026 | Stanley Druckenmiller narrow view | Closed | 0 | 0.49 |
| Q3 2026 | Ray Dalio narrow view | Closed | 0 | 0.18 |
| Q3 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.07 |
| Q3 2026 | Cathie Wood | Closed | 0 | 0.02 |
| Q2 2026 | Stanley Druckenmiller narrow view | Reduced 73.7% | 624,999 | 1.36 |
| Q2 2026 | Larry Robbins | Reduced 23.7% | 5,081,091 | 1.07 |
| Q2 2026 | Ray Dalio narrow view | Added 17.6% | 1,326,678 | 0.03 |
| Q2 2026 | David Einhorn | Reduced 0.8% | 2,886,059 | 0.02 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 10.0% | 490,000 | 0.01 |
| Q2 2026 | Cathie Wood | Added 0.5% | 68,653 | 0.00 |
| Q1 2026 | Larry Robbins | Reduced 60.2% | 6,660,220 | 8.20 |
| Q1 2026 | Stanley Druckenmiller narrow view | Reduced 59.5% | 2,377,285 | 3.59 |
| Q1 2026 | David Einhorn | Reduced 4.8% | 2,910,729 | 0.14 |
| Q1 2026 | Ray Dalio narrow view | Added 49.6% | 1,128,406 | 0.05 |
| Q1 2026 | Cathie Wood | Reduced 35.1% | 68,279 | 0.01 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 8.9% | 544,501 | 0.01 |
| Q4 2025 | Stanley Druckenmiller narrow view | Reduced 64.6% | 5,874,870 | 7.93 |
| Q4 2025 | David Einhorn | Reduced 19.1% | 3,058,734 | 0.79 |
| Q4 2025 | Paul Tudor Jones narrow view | Reduced 23.1% | 500,000 | 0.03 |
| Q4 2025 | Larry Robbins | Added 0.2% | 16,720,209 | 0.02 |
| Q4 2025 | Ray Dalio narrow view | Reduced 12.8% | 754,093 | 0.01 |
| Q4 2025 | Cathie Wood | Reduced 11.4% | 105,131 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q2 2026 | Ray Dalio narrow view | Added 17.6% | 1,326,678 | 0.03 |
| Q2 2026 | Cathie Wood | Added 0.5% | 68,653 | 0.00 |
| Q1 2026 | Ray Dalio narrow view | Added 49.6% | 1,128,406 | 0.05 |
| Q1 2026 | Paul Tudor Jones narrow view | Added 8.9% | 544,501 | 0.01 |
| Q4 2025 | Larry Robbins | Added 0.2% | 16,720,209 | 0.02 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Larry Robbins | Closed | 0 | 3.44 |
| Q3 2026 | David Einhorn | Closed | 0 | 2.50 |
| Q3 2026 | Stanley Druckenmiller narrow view | Closed | 0 | 0.49 |
| Q3 2026 | Ray Dalio narrow view | Closed | 0 | 0.18 |
| Q3 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.07 |
| Q3 2026 | Cathie Wood | Closed | 0 | 0.02 |
| Q2 2026 | Stanley Druckenmiller narrow view | Reduced 73.7% | 624,999 | 1.36 |
| Q2 2026 | Larry Robbins | Reduced 23.7% | 5,081,091 | 1.07 |
| Q2 2026 | David Einhorn | Reduced 0.8% | 2,886,059 | 0.02 |
| Q2 2026 | Paul Tudor Jones narrow view | Reduced 10.0% | 490,000 | 0.01 |
| Q1 2026 | Larry Robbins | Reduced 60.2% | 6,660,220 | 8.20 |
| Q1 2026 | Stanley Druckenmiller narrow view | Reduced 59.5% | 2,377,285 | 3.59 |
| Q1 2026 | David Einhorn | Reduced 4.8% | 2,910,729 | 0.14 |
| Q1 2026 | Cathie Wood | Reduced 35.1% | 68,279 | 0.01 |
| Q4 2025 | Stanley Druckenmiller narrow view | Reduced 64.6% | 5,874,870 | 7.93 |
| Q4 2025 | David Einhorn | Reduced 19.1% | 3,058,734 | 0.79 |
| Q4 2025 | Paul Tudor Jones narrow view | Reduced 23.1% | 500,000 | 0.03 |
| Q4 2025 | Ray Dalio narrow view | Reduced 12.8% | 754,093 | 0.01 |
| Q4 2025 | Cathie Wood | Reduced 11.4% | 105,131 | 0.00 |
History
7 peakQ2 2026: 6 tracked investors
20132026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | – | 68.7K | 68.3K | 105.1K | 118.7K | 120.9K | 90.3K | 100.4K |
| Ray Dalio | – | 1.33M | 1.13M | 754.1K | 864.8K | – | – | 9.4K |
| Stanley Druckenmiller | – | 625.0K | 2.38M | 5.87M | 16.59M | 15.97M | 14.88M | 9.00M |
| Larry Robbins | – | 5.08M | 6.66M | 16.72M | 16.69M | 15.82M | 14.78M | 8.46M |
| David Einhorn | – | 2.89M | 2.91M | 3.06M | 3.78M | 3.78M | 568.2K | 468.6K |
| Paul Tudor Jones | – | 490.0K | 544.5K | 500.0K | 650.0K | 650.0K | 697.5K | 450.0K |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).